Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The term influenza virus vaccine-St. Jude Children's Research Hospital-influenza refers to the intervention protocol used in the FluVIT clinical trial (NCT02649192) conducted at St. Jude Children's Research Hospital. This Phase 2 study evaluated whether oral supplementation with Vitamin A (20,000 IU retinyl palmitate) and Vitamin D3 (2,000 IU cholecalciferol) could enhance the immunogenicity of standard seasonal influenza vaccines in healthy children aged 2 to 8 years. The trial utilized commercially available seasonal vaccines, including the live-attenuated FluMist and various inactivated split-virion vaccines, administered alongside chewable vitamin gummies. The study aimed to determine if these vitamins could act as immunomodulators to improve antibody induction, particularly in children with baseline vitamin deficiencies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on influenza virus vaccine-St. Jude Children's Research Hospital-influenza.